AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23981966 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed plus carboplatin with concurrent radiation therapy (PCb)
Number of subjects: 98
Study 23981966 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed plus cisplatin with concurrent radiation therapy (PC)
Number of subjects: 98
Study 21725230 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-end (ETE) anastomosis
Number of subjects: 128
Study 21725230 — intervention group
Group type: COMPARATOR
Intervention: End-to-side (ETS) anastomosis
Number of subjects: 128
Study 19180356 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin-fortified water (VW)
Number of subjects: 12
Study 19180356 — intervention group
Group type: COMPARATOR
Intervention: Standardized mixed meal (MM)
Number of subjects: 12
Study 17716376 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week lifestyle modification program based on the Choose to Move program; includes audio-taped activity instructions and educational package delivered in weekly home visits.
Number of subjects: 335
Study 17716376 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week lifestyle modification program based on the Choose to Move program.
Number of subjects: 335
Study 17716376 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 335
Study 14767257 — intervention group
Group type: EXPERIMENTAL
Intervention: Gorging (GOR) feeding pattern
Number of subjects: 8
Study 14767257 — intervention group
Group type: COMPARATOR
Intervention: Nibbling (NIB) feeding pattern
Number of subjects: 8
Study 11476107 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanozolol 2 mg twice daily along with cetrizine 10 mg daily
Number of subjects: 58
Study 11476107 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets twice daily along with cetrizine 10 mg daily
Number of subjects: 58
Study 11378602 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterless handrub containing 61% ethanol with emollients (ALC)
Number of subjects: 50
Study 11378602 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine gluconate (CHG)‐containing traditional antiseptic wash
Number of subjects: 50
Study 9433364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 16 mg inhaled daily for 6 weeks
Number of subjects: 20
Study 9433364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8492283 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibliotherapy (written protocol outlining behavioral techniques)
Number of subjects: 0
Study 8492283 — intervention group
Group type: COMPARATOR
Intervention: Stimulant medication
Number of subjects: 0
Study 3303001 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (8 mg/kg over 7 hours) and chlorpromazine (50 mg orally)
Number of subjects: 20
Study 3303001 — intervention group
Group type: COMPARATOR
Intervention: Reduced dose of metoclopramide (6 mg/kg over 7 hours) and chlorpromazine (50 mg orally)
Number of subjects: 20
Study 2334619 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. metoclopramide 10 mg
Number of subjects: 40
Study 2334619 — intervention group
Group type: COMPARATOR
Intervention: i.m. metoclopramide 10 mg
Number of subjects: 40
Study 2334619 — intervention group
Group type: COMPARATOR
Intervention: oral diazepam 10 mg
Number of subjects: 40
Study 2334619 — intervention group
Group type: COMPARATOR
Intervention: i.m. morphine 10 mg
Number of subjects: 40
Study 4416311 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane vaporized into the oxygenator at concentrations of 1.0‐1.5%
Number of subjects: 52
Study 4416311 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 5‐10 mg supplied into the oxygenator
Number of subjects: 52
Study 31917894 — intervention group
Group type: EXPERIMENTAL
Intervention: High-performance washer with high-volume, high-pressure nozzles, heated wash water, and improved filtration system
Number of subjects: 0
Study 31917894 — intervention group
Group type: COMPARATOR
Intervention: Conventional crate washing system
Number of subjects: 0
Study 31374452 — intervention group
Group type: EXPERIMENTAL
Intervention: Move More Pack (print-based intervention)
Number of subjects: 181
Study 31374452 — intervention group
Group type: EXPERIMENTAL
Intervention: Move More Pack (Internet tools)
Number of subjects: 181
Study 31374452 — intervention group
Group type: EXPERIMENTAL
Intervention: Move More Pack (printed components)
Number of subjects: 181
Study 31374452 — intervention group
Group type: EXPERIMENTAL
Intervention: Move More Pack (general use)
Number of subjects: 181
Study 29087880 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg before surgery, then three times daily for 6 doses
Number of subjects: 81
Study 29087880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 25600169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei (LP)
Number of subjects: 220
Study 25600169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum (LF)
Number of subjects: 220
Study 25600169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei (LP) + Lactobacillus fermentum (LF) mixture
Number of subjects: 220
Study 25600169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 25600169 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic groups (LP, LF, LP + LF mixture)
Number of subjects: 220
Study 23281174 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine and Alcohol
Number of subjects: 0
Study 23281174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22452896 — intervention group
Group type: EXPERIMENTAL
Intervention: Afatinib (50 mg per day)
Number of subjects: 697
Study 22452896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 697
Study 19413595 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) infusion (0.5 to 2 microg/kg per min for 30 min)
Number of subjects: 10
Study 19413595 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral extended-release isosorbide mononitrate (120 mg)
Number of subjects: 10
Study 19413595 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaerythritol tetranitrate (160 mg)
Number of subjects: 10
Study 19413595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 17298881 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 microg/day ED-71 for 12 months
Number of subjects: 0
Study 17298881 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5, 0.75 and 1.0 microg/day ED-71 for 12 months
Number of subjects: 0
Study 17298881 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 and 1.0 microg/day ED-71 combined
Number of subjects: 0
Study 17298881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15379144 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 54
Study 15379144 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 54
Study 12439917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal thermochemotherapy and intraperitoneal IL-2 immunotherapy (10 million IU in 500 ml 0.9% sodium chloride daily for 10 times)
Number of subjects: 138
Study 12439917 — intervention group
Group type: COMPARATOR
Intervention: Intraperitoneal thermochemotherapy
Number of subjects: 138
Study 9817305 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus and prednisone with mycophenolate mofetil (2 gm daily)
Number of subjects: 120
Study 9817305 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus and prednisone without mycophenolate mofetil
Number of subjects: 120
Study 8929935 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive array of substance-abuse treatment services
Number of subjects: 323
Study 8929935 — intervention group
Group type: COMPARATOR
Intervention: Intensive case management in addition to other services
Number of subjects: 323
Study 2930809 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (3.0 mu/kg and 6.0 micrograms/kg)
Number of subjects: 8
Study 2930809 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8
Study 328327 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg HBB
Number of subjects: 12
Study 328327 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg HBB
Number of subjects: 12
Study 328327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31826725 — intervention group
Group type: EXPERIMENTAL
Intervention: Low- to moderate-intensity statins
Number of subjects: 2153
Study 31826725 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity statins
Number of subjects: 2153
Study 31826725 — intervention group
Group type: COMPARATOR
Intervention: Statin use (any intensity)
Number of subjects: 2153
Study 28167511 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly financial incentives contingent on observed breastfeeding for 6 months (amount increased from $20 to $70, total possible $270)
Number of subjects: 36
Study 28167511 — intervention group
Group type: COMPARATOR
Intervention: Usual WIC services only
Number of subjects: 36
Study 25070944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulated fluid balance
Number of subjects: 113
Study 25070944 — intervention group
Group type: EXPERIMENTAL
Intervention: Bland-Altman plots
Number of subjects: 113
Study 25070944 — intervention group
Group type: EXPERIMENTAL
Intervention: Pearson correlations
Number of subjects: 113
Study 23415672 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous cisplatin radiochemotherapy
Number of subjects: 68
Study 23415672 — intervention group
Group type: COMPARATOR
Intervention: Sequential systemic carboplatin and paclitaxel followed by percutaneous irradiation
Number of subjects: 68
Study 23415672 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP2 expression in serum
Number of subjects: 68
Study 21819530 — intervention group
Group type: EXPERIMENTAL
Intervention: SQV/r 2000/100 mg
Number of subjects: 123
Study 21819530 — intervention group
Group type: COMPARATOR
Intervention: ATV/r 300/100 mg
Number of subjects: 123
Study 19726386 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength- or weight-training exercise (SWTE) intervention
Number of subjects: 85
Study 17322178 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (including disulfiram, naltrexone, acamprosate)
Number of subjects: 0
Study 17322178 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly, extended-release formulation of naltrexone
Number of subjects: 0
Study 17322178 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial therapy
Number of subjects: 0
Study 15457417 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal liners
Number of subjects: 193
Study 15457417 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene liners
Number of subjects: 193
Study 15457417 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 193
Study 11601765 — intervention group
Group type: COMPARATOR
Intervention: Group A: Fourth generation dentine‐bonding agent and composite restoration (control)
Number of subjects: 30
Study 11601765 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: Paste composed of sodium perborate and hydrogen peroxide for 7 days, sealed with glass ionomer cement
Number of subjects: 30
Study 11601765 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: Paste of sodium perborate and hydrogen peroxide for 7 days, followed by calcium hydroxide paste for 1 week
Number of subjects: 30
Study 9811915 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine prophylaxis started in the prenatal period
Number of subjects: 939
Study 9811915 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine prophylaxis started intra partum
Number of subjects: 939
Study 9811915 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine prophylaxis started within the first 48 hours of life
Number of subjects: 939
Study 9811915 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine prophylaxis started on day 3 of life or later
Number of subjects: 939
Study 9811915 — intervention group
Group type: COMPARATOR
Intervention: No zidovudine prophylaxis
Number of subjects: 939
Study 8080372 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative, nonexcisional therapy (meticulous hair control by natal cleft shaving, improved perineal hygiene, limited lateral incision and drainage for abscess)
Number of subjects: 330
Study 8080372 — intervention group
Group type: COMPARATOR
Intervention: Excisional procedures
Number of subjects: 330
Study 8080372 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 330
Study 2609140 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichlormethiazide 4 mg/d
Number of subjects: 25
Study 2609140 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichlormethiazide and amiloride 2 mg/d each
Number of subjects: 25
Study 4947491 — intervention group
Group type: EXPERIMENTAL
Intervention: Various drug combinations and dosages; treatment duration and rhythms; drug toxicity prevention; home treatment vs. sanatorium treatment; routine home visiting; pretreatment sensitivity tests; short (6-month) intensive courses vs. long-term (18-month) standard courses
Number of subjects: 0
Study 31004286 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% carbomer 980 gel
Number of subjects: 107
Study 31004286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 30577785 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) performed in 66 patients by applying an upper arm blood pressure cuff inflated four times for 5 min to 50 mmHg above systolic blood pressure, followed by deflation for 5 min
Number of subjects: 132
Study 30577785 — intervention group
Group type: COMPARATOR
Intervention: Control group with blood pressure cuff inflated only to 10 mmHg below the patient's diastolic blood pressure
Number of subjects: 132
Study 27381253 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 IU of intranasal OXT
Number of subjects: 31
Study 27381253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 24202712 — intervention group
Group type: EXPERIMENTAL
Intervention: Occult-scar incision laparoscopic cholecystectomy (OSLC)
Number of subjects: 75
Study 24202712 — intervention group
Group type: COMPARATOR
Intervention: Classic three-port laparoscopic cholecystectomy (CLC)
Number of subjects: 75
Study 21848408 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect bonding technique
Number of subjects: 30
Study 21848408 — intervention group
Group type: COMPARATOR
Intervention: Conventional direct-bonding technique
Number of subjects: 30
Study 18485261 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 20 mg
Number of subjects: 581
Study 18485261 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60-120 mg
Number of subjects: 581
Study 18485261 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR 75-225 mg
Number of subjects: 581
Study 18485261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 581
Study 17848625 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg/day
Number of subjects: 120
Study 17848625 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher aspirin doses (162 mg and 325 mg)
Number of subjects: 120
Study 14693632 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 64
Study 14693632 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 64
Study 11679505 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (800 microg)
Number of subjects: 201
Study 11679505 — intervention group
Group type: COMPARATOR
Intervention: Oral misoprostol (800 microg)
Number of subjects: 201
Study 9509846 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management program (health education, muscle relaxation, back massage)
Number of subjects: 40
Study 8205582 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Platinum Professional Toothwhitening System
Number of subjects: 70
Study 8205582 — intervention group
Group type: COMPARATOR
Intervention: Rembrandt Gel Plus
Number of subjects: 70
Study 8205582 — intervention group
Group type: COMPARATOR
Intervention: Placebo paste
Number of subjects: 70
Study 2643864 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 20
Study 2643864 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 20
Study 2643864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 4619059 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine hydrochloride (WR 142490), single dose
Number of subjects: 0
Study 30260740 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich fish oil (600 mg EPA and 260 mg DHA per day for 8 weeks)
Number of subjects: 16
Study 28448329 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program (individualized education session, self-care manual, and weekly phone calls)
Number of subjects: 144
Study 28448329 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 144
Study 25678402 — intervention group
Group type: EXPERIMENTAL
Intervention: PtCr‐PES
Number of subjects: 0
Study 25678402 — intervention group
Group type: COMPARATOR
Intervention: TE‐PES
Number of subjects: 0
Study 25678402 — intervention group
Group type: COMPARATOR
Intervention: BMS
Number of subjects: 0
Study 24089434 — intervention group
Group type: EXPERIMENTAL
Intervention: Action observational training (n = 15)
Number of subjects: 30
Study 24089434 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 30
Study 21106710 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 5 mg/d for children < 40 kg and 10 mg/d for children ≥ 40 kg
Number of subjects: 139
Study 21106710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 18210952 — intervention group
Group type: EXPERIMENTAL
Intervention: High compression therapy plus amelogenin
Number of subjects: 83
Study 18210952 — intervention group
Group type: COMPARATOR
Intervention: High compression therapy alone
Number of subjects: 83
Study 17109671 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide
Number of subjects: 0
Study 17109671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14667945 — intervention group
Group type: COMPARATOR
Intervention: Obstacle crossing (2.5%, 5%, 10%, and 15% of height)
Number of subjects: 15
Study 14667945 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased M-L motion of the COM during obstacle crossing
Number of subjects: 15
Study 10960405 — intervention group
Group type: COMPARATOR
Intervention: 0% N(2)O (Air)
Number of subjects: 125
Study 10960405 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% N(2)O (N30)
Number of subjects: 125
Study 10960405 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% N(2)O (N40)
Number of subjects: 125
Study 10960405 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% N(2)O (N50)
Number of subjects: 125
Study 10960405 — intervention group
Group type: EXPERIMENTAL
Intervention: 67% N(2)O (N67)
Number of subjects: 125
Study 10960405 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% N(2)O (N40-a)
Number of subjects: 125
Study 9395642 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8192301 — intervention group
Group type: EXPERIMENTAL
Intervention: Small clinical trials
Number of subjects: 0
Study 3569028 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 900 mg iv q8h (treatment C)
Number of subjects: 6
Study 3569028 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 600 mg iv q6h (treatment A)
Number of subjects: 6
Study 3569028 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin phosphate 600 mg iv q8h (treatment B)
Number of subjects: 6
Study 29783893 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-tDCS
Number of subjects: 35
Study 29783893 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 35
Study 24893766 — intervention group
Group type: EXPERIMENTAL
Intervention: LKM512
Number of subjects: 44
Study 24893766 — intervention group
Group type: COMPARATOR
Intervention: KYNA injection
Number of subjects: 44
Study 23147329 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine with epinephrine 1:100,000 (L100)
Number of subjects: 43
Study 23147329 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with epinephrine 1:200,000 (A200)
Number of subjects: 43
Study 20545244 — intervention group
Group type: EXPERIMENTAL
Intervention: Agua das Pedras (sodium-rich carbonated mineral water), 500 ml/day for 7 weeks
Number of subjects: 17
Study 20545244 — intervention group
Group type: COMPARATOR
Intervention: Agua Vitalis (control), 500 ml/day for 7 weeks
Number of subjects: 17
Study 18833588 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-focused educational resource (filofax-style folder with inserts)
Number of subjects: 32
Study 18833588 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational resource)
Number of subjects: 32
Study 16278522 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide-type diuretics
Number of subjects: 0
Study 16278522 — intervention group
Group type: COMPARATOR
Intervention: Other antihypertensive drug classes
Number of subjects: 0
Study 12412675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone (100 microg b.i.d.)
Number of subjects: 40
Study 12412675 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg, once a day)
Number of subjects: 40
Study 10341919 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage (n = 43)
Number of subjects: 100
Study 10341919 — intervention group
Group type: COMPARATOR
Intervention: No drainage (n = 57)
Number of subjects: 100
Study 10341919 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 8547195 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive follow-up group (6 monthly chest X-rays and bone scans)
Number of subjects: 0
Study 8547195 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinical examination only)
Number of subjects: 0
Study 2403473 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-administered cognitive-behavioral treatment
Number of subjects: 0
Study 2403473 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-administered cognitive-behavioral treatment
Number of subjects: 0
Study 2403473 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 0